Sprekers
Maak kennis met de sprekers op de CBG Collegedag 2025.
Executive Director, European Medicnes Agency
Emer Cooke has been the Executive Director of the European Medicines Agency, based in Amsterdam, since November 2020. She also holds the role of Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA).
Between November 2016 and November 2020, she was the Director responsible for all medical product related regulatory activities at the World Health Organization in Geneva.
Ms. Cooke is a pharmacist with Master’s degrees in Science and Business Administration from Trinity College Dublin. She has over 30 years’ experience in international regulatory affairs and held management positions at the EMA as Head of Inspections and Head of International Affairs respectively from 2002 until 2016.
She has also worked in the Pharmaceuticals unit of the European Commission, where intra-alia, she was responsible for international collaboration, EU enlargement and the orphan medicines regulation for the European Pharmaceutical Industry Association (EFPIA) and in various industry and regulatory positions in Ireland.
In 2021 she received the Muckross (her alma mater) Woman of the Year award. In 2022 she received European Movement Ireland’s “European of the Year” award. In 2023 she was awarded an honorary doctorate by the Royal College of Surgeons Ireland (RCSI) University of Medicines and Health Sciences.
Co-founder and chair of the World Duchenne Organization
Elizabeth, for 30 years practicing orthodontist, founded in 1994 the dutch Duchenne Parent Project, a Duchenne research foundation and patient organization.
She is co-founder and chair of the World Duchenne Organization since 2005. She is the mother of an adult son with Duchenne Muscular Dystrophy (DMD).
She was a board member of EURORDIS. She is involved in the training of other patient advocates/experts in the rare disease community.
At the European Medicines Agency (EMA) she serves as patient expert and member of the Patient Consumer Working Party. Elizabeth is a member of the Advisory Board of EMA’s Data Analysis and Real World Interrogation Network (DARWIN EU).
She is a strong advocate for optimal (re)use of health data and took the initiative for projects and workshops regarding data collection with patient organization in the lead, FAIRification of health data, personal health data-lockers and development of PRO(M)s. Other initiatives include the annual Duchenne Care Conference where more than 700 HCP’s from over 70 countries participate, the global Accredited Duchenne Care centers program, Duchenne Emergency program and the World Duchenne Organization which received recognition from the United Nations.
Elizabeth is involved in over 50 publications regarding Standards of Care and drug development for DMD, related to development of outcome measures, patient preferences, the role of biomarkers and the publication of the white paper over Newborn Screening for Duchenne MD. She participates in several EU funded projects, such as BIND, BEAMER (IMI) and Trials@home (IMI), Screen4Care as well as in the European Reference Network for Neuromuscular Disorders EURO-NMD.
Collegevoorzitter CBG
Ton de Boer is sinds 1 augustus 2017 voorzitter van het CBG. Hij is arts, klinisch farmacoloog en epidemioloog.
Naast zijn voorzitterschap bij het CBG was hij tot zijn emeritaat in juni 2022 actief als hoogleraar Grondslagen van de Farmacotherapie aan de Universiteit Utrecht.
De Boer begon zijn carrière als arts-assistent Interne Geneeskunde en promoveerde op het gebied van klinische farmacologie. Zijn expertise ligt dan ook op het gebied van klinische farmacologie, farmaco-epidemiologie en farmacogenetica, met name van cardiovasculaire geneesmiddelen. Naast zijn voorzitterschap bij het CBG verzorgt hij af en toe postacademisch onderzoek voor apothekers (via PAOFarmacie).
Directeur aCBG
Paula Loekemeijer is directeur/secretaris van het aCBG sinds 2021.
Daarvoor bekleedde Paula gedurende twintig jaar directiefuncties bij verschillende overheidsinstanties. Voor haar huidige functie was ze zes jaar directeur Veiligheidsonderzoeken en Bedrijfsvoering bij de Algemene Inlichtingen en Veiligheidsdienst (AIVD). Hoewel de AIVD en het CBG inhoudelijk sterk verschillen, is het CBG niet vreemd voor Paula: na haar studie farmacie in Leiden en de apothekersopleiding in Utrecht werkte ze al een aantal jaar als wetenschappelijk beoordelaar bij het CBG.